GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy HONG KONG, Jan. 5, 2026 /PRNewswire/ — GenEditBio Limited ("GenEditBio"), a clinical-stage… CISION PRNewswireJanuary 5, 2026
GMA Capital Partners Joins Responsible Investment Association Australasia SINGAPORE, Jan. 5, 2026 /PRNewswire/ — GMA Capital Partners has been approved… CISION PRNewswireJanuary 5, 2026
Press Release KT&G's Indonesian Factory Acquires 'ISO 45001' Certification – Establishes overseas manufacturing system meeting global health & safety standards following… CISION PRNewswireJanuary 5, 2026
C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5,… CISION PRNewswireJanuary 5, 2026
Press Release Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving… CISION PRNewswireJanuary 5, 2026
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes -The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled… CISION PRNewswireJanuary 5, 2026
CTA: Despite Tariffs and Economic Headwinds, U.S. Consumer Tech Revenue to Hit $565 Billion in 2026 LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — As tariff pressures and economic uncertainty… CISION PRNewswireJanuary 5, 2026
Babies Bliss Establishes a New Standard for Fertility Wellness in Singapore with a Whole-Person, Cycle-Aware Model Singapore-based Fertility Wellness House positions complementary care as long-term support alongside IVF… CISION PRNewswireJanuary 5, 2026